Loading...
Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer
BACKGROUND: Metastatic castration-resistant prostate cancer (mCRPC) is the lethal form of the disease. Several recent studies have identified genomic alterations in mCRPC, but the clinical implications of these genomic alterations have not been fully elucidated. OBJECTIVE: To use whole-genome sequen...
Na minha lista:
| Udgivet i: | Eur Urol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6764911/ https://ncbi.nlm.nih.gov/pubmed/30928160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.03.020 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|